BiotechTube
Home/Celldex Therapeutics/Sarah Cavanaugh
SC

Sarah Cavanaugh

Senior Vice President, Corporate Affairs and Administration

Celldex Therapeutics

Therapeutic Areas

Inflammatory DiseasesOncologyAllergic DiseasesAutoimmune Disorders

Celldex Therapeutics Pipeline

DrugIndicationPhase
BarzolvolimabChronic Spontaneous Urticaria (CSU)Phase 3
CDX-0159Prurigo Nodularis (PN)Phase 2
CDX-1140Oncology (Solid Tumors)Phase 1/2
CDX-527Oncology (Solid Tumors)Phase 1
CDX-622Inflammatory DiseasesPhase 1
CDX-585Oncology (Solid Tumors)Preclinical

Leadership Team at Celldex Therapeutics

AS
Anthony S. Marucci
Founder, President, Chief Executive Officer and Director
TK
Tibor Keler, Ph.D.
Founder, Executive Vice President and Chief Scientific Officer
View full Celldex Therapeutics profile